PA
HBAN icon

PharVision Advisers’s Huntington Bancshares HBAN Stock Holding History

PharVision Advisers’s Portfolio HBAN Stock Details HBAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,090
Closed -$186K – 717
2025
Q2 		$186K Buy
+11,090
New +$167K 0.27% 213

Other funds holding HBAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's HBAN Position: Q3 2025 in Review

PharVision Advisers sold out of Huntington Bancshares (HBAN) in Q3 2025, closing a stake of 11,090 shares — an estimated $186K sold.

PharVision Advisers first reported a position in HBAN in Q2 2025 and held it in 1 quarter. The position peaked at $186K in Q2 2025. 1,011 funds tracked by Wall St. Rank hold HBAN as of Q3 2025.

  • PharVision Advisers reported no remaining Huntington Bancshares position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 11,090 Huntington Bancshares shares in Q3 2025, an estimated $186K.
  • PharVision Advisers first reported a position in Huntington Bancshares in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's Huntington Bancshares position peaked at $186K in Q2 2025.
  • 1,011 funds tracked by Wall St. Rank held Huntington Bancshares as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.